$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled triglyceride nutrition for hypercatabolic mammals 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A01N-037/02
출원번호 US-0461077 (1983-01-26)
발명자 / 주소
  • Blackburn George L. (Cambridge MA)
출원인 / 주소
  • KabiVitrum AB (Stockholm SEX 03)
인용정보 피인용 횟수 : 33  인용 특허 : 4

초록

Method and composition for enhancing protein anabolism in an hypercatabolic mammal. The method comprises parenterally administering to the mammal nutritionally sufficient sources for amino acids, carbohydrates and lipids, the lipids comprising a controlled triglyceride source which, on hydrolysis, y

대표청구항

A method of enhancing protein anabolism in a hypercatabolic mammal, the method comprising parenterally administering to the mammal nutritionally sufficient sources for carbohydrates, amino acids and lipids, the lipid source comprising an emulsion of triglycerides which, on hydrolysis, yields both lo

이 특허에 인용된 특허 (4)

  1. Cavazza Claudio (35 ; Via Marocco 00144 Rome ITX), Acyl-carnitine and use thereof in parenteral administration of triglycerides.
  2. Schmidl Mary K. (Emeryville CA), Liquid elemental diet.
  3. Kashiwabara Norio (Tokyo JPX) Maruyama Hirotaka (Kawagoe JPX) Ishii Tetuo (Hidaka JPX) Kondo Satoru (Tokyo JPX), Nutrient composition suitable for enteral feeding.
  4. Gatzen Carl-Jacob (Pannebckerstr. 20 Dsseldorf DEX) Poethen Hartmut (Berger Allee 3 Dsseldorf DEX) Sion Heribert (Graf-Adolf-Platz 3 Dsseldorf DEX), Process for the lowering of increased levels of cholesterol and neutral fat in the blood of humans.

이 특허를 인용한 특허 (33)

  1. Koyama, Hironari; Okada, Masaaki, Agents for promoting fattening of animals and method of promoting fattening.
  2. Koyama,Hironari; Okada,Masaaki, Agents for promoting fattening of animals and method of promoting fattening.
  3. Bistrian Bruce R. (Ipswich MA) Babayan Vigen K. (Waban MA) Blackburn George L. (Jamaica MA) Mascioli Edward A. (Needham MA), Dietary supplement utilizing w 상세보기
  • Ernest, Stephen P., Enteral formulation.
  • Ernest,Stephen P., Enteral formulation.
  • Forse R. Amour ; Bell Stacey J. ; Burke Peter, Enteral formulation: low in fat and containing protein hydrolysates.
  • Forse R. Armour ; Bell Stacey J. ; Burke Peter, Enteral formulation: low in fat and containing protein hydrolysates.
  • Henderson, Samuel T., Enzymatic synthesis of acetoacetate esters and derivatives.
  • Sisco, Tamea Rae; Skinner, Keith Kenneth; Keller, Theodore R, High potency clinical anti-craving treatment and method of use.
  • Bistrian Bruce R. (Ipswich MA) Babayan Vigen K. (Waban MA) Blackburn George L. (Jamaica Plain MA), Kernel oils and disease treatment.
  • Okazaki Akio (Aichi JPX) Bethunou Ikuo (Aichi JPX) Tsuchida Naoki (Hokkaido JPX) Hayashi Masaharu (Wakayama JPX), Method for breeding infant livestock and feed composition.
  • Cotter Richard (Libertyville IL) Johnson Robert C. (Westchester IL) Rowe W. Bruce (Chicago IL) Young Susan K. (North Chicago IL), Method for directed visceral metabolism of medium chain triglycerides.
  • Henderson, Samuel T., Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders.
  • Bistrian Bruce R. (Ipswich MA) Babayan Vigen R. (Waban MA) Blackburn George L. (Jamaica Plain MA), Nutritional supplement for treatment of cancer cachexia.
  • Cotter Richard (Libertyville IL) Johnson Robert C. (Westchester IL) Ward Michael (McHenry IL) Madsen David C. (Libertyville IL) Valicenti Anthony J. (Deerfield IL) Menard Michael P. (Grayslake IL) Tu, Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular,.
  • Nilsen Stephen James ; Walden Gary Lyle, Oral compositions having enhanced mouth-feel.
  • Nilsen Stephen James ; Walden Gary Lyle, Oral compositions having enhanced mouthfeel.
  • Sisco, Tamea Rae; Skinner, Keith Kenneth; Keller, Theodore, Oral high potency clinical anti-craving treatment and method of use.
  • Hunter John E. (Cincinnati OH) Eck Jack R. (Newport KY), Reduced calorie peanut butter.
  • Babayan Vigen K. (Waban MA) Blackburn George L. (Jamaica Plain MA) Bistrian Bruce R. (Ispwich MA), Structured lipid containing dairy fat.
  • DeMichele Stephen Joseph ; Karlstad Michael Donald ; Bistrian Bruce Ryan ; Mascioli Edward Anthony, Structured lipid containing gamma-linolenic or dihomogamma-linolenic fatty acid residue, a medium chain (C6-C12) Fatty a.
  • Yang David K. (Cincinnati OH), Tailored triglycerides having improved autoignition characteristics.
  • Babayan Vigen K. (178 Beethoven Ave. Waban MA 02168) Blackburn George L. (241 Perkins Jamiaca Plains MA 02130) Bistrian Bruce R. (189 Argilla Rd. Ipswich MA 01938), Triglyceride preparations for the prevention of catabolism.
  • Henderson, Samuel T., Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function.
  • Henderson, Samuel T., Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function.
  • Henderson, Samuel T., Use of ketogenic compounds for treatment of age-associated memory impairment.
  • Henderson, Samuel T., Use of ketogenic compounds for treatment of age-associated memory impairment.
  • Henderson, Samuel T, Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II.
  • Henderson, Samuel T., Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II.
  • Henderson, Samuel T., Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II.
  • Henderson, Samuel T., Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism.
  • Henderson, Samuel T., Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II.
  • Cotter Richard ; Tucker Hugh, Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients.
  • 섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로